An interaction of cis platin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro

References

• ALAPETITE, C., LEVY, Y., BAROCHE, C., BARRETT, J. M., SALLES, B., AVERBECK, D. and MOUSTACCHI, E., 1993, An activated ras oncogene did not modify the radiosensitivity of a human mammary epithelial cell line but produced a specific acquired resistance to CDDP. Radiation Oncol-ogy Biology, 27 (suppl.), 303.
   Google Scholar
• BEDFORD, P., SHELLARD, S. A., WALKER, M. C., WHELAN, R. D. H., MASTERS, J. R. W. and HILL, B. T., 1986, Differential expression of collateral sensitivity or resistance to cisplatin in human bladder carcinoma cell lines pre-exposed in vitro to either X-irradiation or cisplatin. International Journal of Cancer, 40, 681–686.
   Google Scholar
• BELLAMY, A. S., WHELAN, R. D., LOCK, R. B. and HILL, B. T., 1991, Effects of fractionated X-irradiation on subsequent response to acute X-irradiation in two human tumor cell lines in vitro. International Journal of Radiation Biology, 51, 681–691.
   Google Scholar
• GARDE, P. and LAVAL, F., 1981, Effect of cis-dichlorodiammine-platinum II and X-rays on mammalian cell survival.
   Google Scholar
• International Journal of Radiation Oncology, Biology and Physics, 7, 929–933.
   Google Scholar
• COUGHLIN, C. T. and RICHMOND, R. C., 1985, Platinum based combined modality approach for locally advanced head and neck carcinoma. International Journal of Radiation Oncology, Biology and Physics, 11, 915–919.
   PubMed Web of Science ®Google Scholar
• COUGHLIN, C.T. and RICHMOND, R.C., 1989, Biological and clinical developments of cisplatin combined with radia-tion: concepts, utility, projections of new trials, and the emergence of carboplatin. Seminors in Oncology, 16\(Suppl. 6), 31–43.
   PubMedGoogle Scholar
• CROOILIMANS, R. P. M. A., SCHWACHOFER, I. M. H. and HOOGENHOUT, J., 1991, The influence of pre-irradiation on the survival of two head and neck squamous cell carcinoma cell line. Anticancer Research, 11, 297–300.
   Google Scholar
• DEMPKE, W. C. M., WHELAN, R. D. and HILL, B. T., 1992, Expression of resistance to etoposide and vincristine in vitro and in vivo after X-irradiation of ovarian tumor cells. Anticancer Drugs, 3, 395–399.
   Google Scholar
• DEWIT, L., OUSSOREN, Y. and BARTELINK, H., 1986, The effects of cis-diamminedichloroplatinum (II) and radiation on the proliferation kinetics of mouse duodenal crypt cells and on a partially synchronized crypt cell population. International Journal of Radiation Oncology, Biology and Physics, 12, 1977–1985.
   PubMedGoogle Scholar
• DEWIT, L., 1987, Combined treatment of radiation and cis-diamminedichloroplatinum (II): A review of experi-mental and clinical data. International Journal of Radia-tion Oncology, Biology and Physics, 13, 403–426.
   PubMed Web of Science ®Google Scholar
• DOUPLE, E. B. and RICHMOND, R. C., 1978, Platinum complexes or sensitizers of hypoxic mammalian cells. British Journal of Cancer, 37, 98–102.
   Google Scholar
• DREWINKO, B. and GOTTLIEB, J. A., 1975, Action of cis-dichlorodiammineplatinum (II) at the cellular level. Cancer Chemotherapy Reports, 59, 665–673.
   PubMedGoogle Scholar
• EICHHOLTZ-WIRTH, H. and HIETEL, B., 1994, Cisplatin resistance in mouse fibrosarcoma cells after low-dose irradiation in vitro and in vivo. British Journal of Cancer, 70, 579–584.
   PubMed Web of Science ®Google Scholar
• HILL, B. T., SHELLARD, S. A., HOSKING, L. K., FICHTINGER-SCHEPMAN, A. M. J. and BEDFORD, P., 1990, Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated x-irraditation. International Journal of Radiation Oncology, Biology and Physics, 19, 75–83.
   Google Scholar
• HILL, B. T., SHELLARD, S. A., HOSKING, L. K., DEMPKE, W. C. M., FICHTINGER-SCHEPMAN, A. M. J., TONE, T., SCANLON, K. J. and WHELAN, R. D. H., 1992, Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collat-eral sensitivity to methotrexate. Cancer Research, 52, 3110–3118.
   Google Scholar
• HILL, B. T., 1991, Interaction between antitumor agents and radiation and the expression of resistance. Cancer Treatment Reviews, 18, 149–190.
   PubMed Web of Science ®Google Scholar
• KORBELIK, M. and SKOV, K. A., 1989, Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses. Radiation Research, 119,145–156.
   PubMed Web of Science ®Google Scholar
• SCHWACHOFER, J. M. H. and KYRIAZIS, A. P., YAGODA, A., KEREIAKES, J. G., KYRIAZIS, A. A. and WHITMORE JR, W. F., 1983, Experimental studies on the radiation-modifying effect of cis-diamminedichloro-platinum II (DDP) in human bladder transitional cell carcinoma grown in nude mice. Cancer, 52, 452–457.
   Google Scholar
• LELIEVELD, p., SCOLES, M. A., BROWN, J. M. and KALLMAN, R. F., 1985, The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on RIF-1 tumor and normal mouse skin. Inter-nationalJournal of Radiation Oncology, Biology and Physics, 11, 111–121.
   PubMedGoogle Scholar
• MCLEAN, S., HOSKING, L. K. and HILL, B. T., 1993, Dominant expression of multiple drug resistance after in vitro x-irradiation exposure in intraspecific chinese hamster ovary hybrid cells. Journal of the National Cancer Institute, 85, 48–53.
   PubMedGoogle Scholar
• MEYN, R. E., MEISTRICH, M. L. and WHITE, R. A., 1980, Cycle-dependent anticancer drug cytotoxicity in mammalian cells synchronized by centrifugal elutriation. Journal of the National Cancer Institute, 64, 1215–1219.
   PubMedGoogle Scholar
• MITSUHASHI, N., TAKAHASHI, T., NOZAKI, M., MATSUMOTO, H., SAKURAI, H., TAKAHASHI, M. and NIIBE, H., 1993, Estab-lishment and characterization of a rat yolk sac tumor cell line, NMT-1, producing alpha-fetoprotein, with potential for lymphatic metastasis. Japanese Journal of Cancer Research, 84, 1287–1291.
   PubMedGoogle Scholar
• MITSUHASHI, N., TAKAHASHI, T., SAKURAI, H., NOZAKI, M., AKIMOTO, T., HASEGAWA, M., SAITO, y., MATSUMOTO, H., HIGUCHI, K., MAEBAYASHI, K. and NIIBE, H., 1996, A radioresistant variant cell line, NMT-1R, isolated from a radiosensitive rat yolk sac tumor cell line, NMT-1: differences of early radiation-induced morphological changes, especially apoptosis. International Journal of Radiation Biology, 69, 329–336.
   PubMed Web of Science ®Google Scholar
• Nus, A. H., 1985, Radiation and platinum drug interaction review. InternationalJournal of Radiation Oncology, Biology and Physics, 11, 297–314.
   Google Scholar
• NOZAKI, M., 1992, Biological and histological characteristics of experimental yolk sac tumor developed by fetectomy and their usefulness in radiotherapeutic experiments. Journal of the Japanese Society for Therapeutic Radiology and Oncology, 4, 33–43.
   Google Scholar
• OSMAK, M. and PEROVIC, S., 1989, Multiple fractions of gamma rays induced resistance to cis-dichloro-diammine-platinum (II) and methotrexate in human HeLa cells. International Journal of Radiation Oncology, Biology and Physics, 16, 1537–1541.
   PubMedGoogle Scholar
• OVERGAARD, J. and KHAN, A. R., 1981, Selective enhancement of radiation response in C3H mammary carcinoma by cisplatin. Cancer Treatment Reports, 65, 501–503.
   PubMedGoogle Scholar
• REDPATH, J. L., HYDEN, E. C. and SUN, C., 1995, Induction of cisplatinum sensitivity without alteration in radiation sensitivity by fractionated radiation treatment of a human laryngeal squamous cell carcinoma cell line. International Journal of Radiation Oncology, Biology and Physics, 32, 681–685.
   PubMedGoogle Scholar
• RoBEwrs, J. J. and ERAVAL, H. N. A., 1980, Repair of cisplatinum (II) diamminedichloride-induced DNA damage and cell sensitivity. In Cisplatin- Current Status and New Developments, edited by A. W. Prestayko, S. T. Crooke and S. K. Carter (New Yolk: Academic), pp. 57–77.
   Google Scholar
• SCHWACHOFER, J. H. M., CROOIJMANS, R. P. M. A., HOOGENHOUT, J., KAL, H. B. and THEEUWES, A. G. M., 1991, Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Inter-national Journal of Radiation Oncology, Biology and Physics, 20, 1235–1241.
   Google Scholar
• SHARM, R. and SCHIMKE, R. T., 1980, Enhancement of the frequency of methotrexate resistance by y-irradiation in chinese hamster and mouse 3T6 cells. Cancer Research, 49, 3861–3866.
   Google Scholar
• SKLAR, M. D. and PROCHOWNIK, E. V., 1991, Modulation of cisplatinum resistance in friend erythroleukemia cells by c-myc. Cancer Research, 51, 2118–2123.
   PubMed Web of Science ®Google Scholar
• SORENSON, C. M. and EASTMAN, A., 1988, The mechanism of cis-diamminedichloroplatinum (II) induced cytotoxicity: the role of G2 arrest and DNA double-strand breaks. Cancer Research, 48, 4484–4488.
   PubMed Web of Science ®Google Scholar
• SORENSON, C. M., BARRY, M. A. and EASTMAN, A., 1990, Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. Journal of the National Cancer Institute, 82, 749–755.
   PubMed Web of Science ®Google Scholar
• SUN, J. R. and BROWN, M., 1993, Lack of differential radio-sensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Radiation Research, 133, 252–256.
   PubMed Web of Science ®Google Scholar
• TANABE, M., GODAT, D. and KALLMAN, R. F., 1987, Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/ST tumor and normal tissues of C3H/KM mouse. Inter-nationalJournal of Radiation Oncology, Biology and Physics, 13, 1523–1532.
   PubMedGoogle Scholar
• WALLNER, K. E. and LI, G., 1987, Effects of cisplatin resistance on cellular radiation response. International Journal of Radiation Oncology, Biology and Physics, 13, 587–591.
   PubMed Web of Science ®Google Scholar
• WILKINS, D., RAAPHORST, G. P., SMITH, I. C. P., SUTHERLAND, G. and SAUNDERS, J. Y, 1991, Inhibition of PLDR by cisplatin in the 9L rat gliosarcoma cell line. Radiation Research, 12, 445.
   Google Scholar
• YAN, R. and DURAND, R. E., 1991, The response of hypoxic cells in SCCVII murine tumors to treatment with cisplatin and X rays. International Journal of Radiation Oncology, Biology and Physics, 20, 271–274.
   PubMed Web of Science ®Google Scholar
• YANG, L., DOUPLE, E. B. and WANG, H., 1995, Irradiation enhances cellular uptake of carboplatin. International Journal of Radiation Oncology, Biology and Physics, 33, 641–646.
   PubMed Web of Science ®Google Scholar